Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

about

The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment.Intratumoral CD8+ T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor Immunity.

P2860

Q42323496-D0883832-D5BB-47BD-9BC6-703D6621FEED Q47666073-D7D49B13-8A2A-4174-A85A-57024FAF88BC

P2860

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

Item

http://www.wikidata.org/entity/Q38791826

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

@en

type

Item

label

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

@en

prefLabel

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

@en

P1476

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

@en

P2093

Maria-Luisa Alegre

http://www.w3.org/2001/XMLSchema#string

Michelle L Miller

http://www.w3.org/2001/XMLSchema#string

Thomas F Gajewski

http://www.w3.org/2001/XMLSchema#string

P2860

IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a

Cancer immunotherapy

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Enhancement of antitumor immunity by CTLA-4 blockade

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

T cell-NF-κB activation is required for tumor control in vivo

Controlled expression of transgenes introduced by in vivo electroporation.

Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells.

P304

2933-2938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1501144

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26903482

http://www.w3.org/2001/XMLSchema#string

P932

4799771

http://www.w3.org/2001/XMLSchema#string

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

about

P2860

P2860

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932